JP2013522368A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522368A5
JP2013522368A5 JP2013501397A JP2013501397A JP2013522368A5 JP 2013522368 A5 JP2013522368 A5 JP 2013522368A5 JP 2013501397 A JP2013501397 A JP 2013501397A JP 2013501397 A JP2013501397 A JP 2013501397A JP 2013522368 A5 JP2013522368 A5 JP 2013522368A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
och
conr
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013501397A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013522368A (ja
JP5964809B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/029425 external-priority patent/WO2011119605A2/en
Publication of JP2013522368A publication Critical patent/JP2013522368A/ja
Publication of JP2013522368A5 publication Critical patent/JP2013522368A5/ja
Application granted granted Critical
Publication of JP5964809B2 publication Critical patent/JP5964809B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013501397A 2010-03-22 2011-03-22 オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体 Expired - Fee Related JP5964809B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US31617510P 2010-03-22 2010-03-22
US61/316,175 2010-03-22
US39414810P 2010-10-18 2010-10-18
US61/394,148 2010-10-18
US42191510P 2010-12-10 2010-12-10
US61/421,915 2010-12-10
PCT/US2011/029425 WO2011119605A2 (en) 2010-03-22 2011-03-22 Carboxamide biosiosteres of opiates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016078368A Division JP2016175910A (ja) 2010-03-22 2016-04-08 オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体

Publications (3)

Publication Number Publication Date
JP2013522368A JP2013522368A (ja) 2013-06-13
JP2013522368A5 true JP2013522368A5 (enExample) 2014-05-08
JP5964809B2 JP5964809B2 (ja) 2016-08-03

Family

ID=44072680

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013501397A Expired - Fee Related JP5964809B2 (ja) 2010-03-22 2011-03-22 オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体
JP2016078368A Pending JP2016175910A (ja) 2010-03-22 2016-04-08 オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016078368A Pending JP2016175910A (ja) 2010-03-22 2016-04-08 オピオイド受容体リガンドとしてのカルボキサミド基を含有するモルヒネ誘導体

Country Status (7)

Country Link
US (4) US8436175B2 (enExample)
EP (1) EP2550253B9 (enExample)
JP (2) JP5964809B2 (enExample)
AU (1) AU2011232628B2 (enExample)
CA (1) CA2793725C (enExample)
ES (1) ES2582306T3 (enExample)
WO (1) WO2011119605A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014137A2 (en) * 2005-07-21 2007-02-01 Rensselaer Polytechnic Institute 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
US9119848B2 (en) 2009-12-04 2015-09-01 Alkermes Pharma Ireland Limited Morphinan derivatives for the treatment of drug overdose
AU2011232628B2 (en) 2010-03-22 2015-04-09 Rensselaer Polytechnic Institute Morphinane derivatives containing a carboxamide group as opioid receptor ligands
HUE065427T2 (hu) 2010-08-23 2024-05-28 Alkermes Pharma Ireland Ltd Eljárások antipszichotikum által indukált súlygyarapodás kezelésére
SMT201700400T1 (it) 2011-06-29 2017-09-07 Alkermes Inc Composti oppioidi ad azione periferica
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
EP3003311A2 (en) 2013-05-24 2016-04-13 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
CA2911231C (en) 2013-05-24 2021-12-07 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
CN103992272B (zh) * 2014-06-09 2016-05-11 安徽省逸欣铭医药科技有限公司 一种盐酸喷他佐辛酯、其制备方法及其用途
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES252980A1 (es) 1958-10-30 1960-11-01 Boehringer Sohn Ingelheim Procedimiento para la obtencion de nuevas sales cuaternarias, terapéuticamente valiosas, de la normorfina y de sus derivados
CH581624A5 (enExample) 1970-08-14 1976-11-15 Sumitomo Chemical Co
US3856795A (en) 1972-04-25 1974-12-24 American Home Prod Process for preparation of secondary amines from tertiary amines
DE2254298A1 (de) 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
US3957793A (en) 1974-09-20 1976-05-18 Sterling Drug Inc. Hydroxyiminobenzazocines
US4032529A (en) 1974-09-20 1977-06-28 Sterling Drug Inc. Aminomethanobenzazocine intermediates
US4205171A (en) 1976-01-12 1980-05-27 Sterling Drug Inc. Aminomethanobenzazocines and nitromethanobenzazocines
US4176186A (en) 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
US4373139A (en) 1979-04-30 1983-02-08 Motorola, Inc. Detectors
FR2514644A1 (fr) 1981-10-19 1983-04-22 Sanofi Sa Composition pharmaceutique a action antagoniste peripherique des opiaces
US4374139A (en) 1981-11-09 1983-02-15 Hoffmann-La Roche Inc. Levorotatory N-substituted acylmorphinans useful as analgesic agents
US4649200A (en) 1986-05-08 1987-03-10 Regents Of The University Of Minnesota Substituted pyrroles with opioid receptor activity
US4939264A (en) 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
US4929622A (en) 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
US5258386A (en) 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
US5607941A (en) 1992-06-26 1997-03-04 Boehringer Ingelheim Kg Useful for treating neurodegenerative diseases
SE9103745D0 (sv) 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
EP0632041A1 (en) 1993-07-01 1995-01-04 Katholieke Universiteit Nijmegen New morphine derivatives having improved analgesic and narcotic properties
BR9707136A (pt) 1996-01-10 1999-08-31 Smithkline Beecham Spa Derivados morfinóides condesados em heterociclo (ii)
ES2121553B1 (es) 1996-12-23 1999-06-16 Univ Santiago Compostela Nuevos endoperoxidos morfinicos funcionalizados en posiciones c-6 y c-14 del anillo c y procedimiento para su obtencion.
GB9709972D0 (en) 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
WO2001012197A1 (en) 1999-08-13 2001-02-22 Southern Research Institute Pyridomorphinans, thienomoprhinans and use thereof
ES2278647T3 (es) 1999-11-29 2007-08-16 Adolor Corporation Nuevos procedimientos y composiciones que comprenden opioides y antagonistas de opioides.
JP4340437B2 (ja) 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
US7375082B2 (en) 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
DE60302157T2 (de) 2002-05-30 2006-07-27 Eli Lilly And Co., Indianapolis Opioidrezeptorantagonisten
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
AU2003281060A1 (en) 2002-07-16 2004-02-02 Rensselaer Polytechnic Institute Process for conversion of phenols to carboxamides via the succinimide esters
WO2004045562A2 (en) 2002-11-18 2004-06-03 The Mclean Hospital Corporation Mixed kappa/mu opioids and uses thereof
RU2346996C2 (ru) 2004-06-29 2009-02-20 ЮРОПИЭН НИКЕЛЬ ПиЭлСи Усовершенствованное выщелачивание основных металлов
PT2251330E (pt) 2004-11-05 2012-07-20 Rensselaer Polytech Inst 4-hidroxibenzomorfanos
MX2007006790A (es) * 2004-12-07 2007-08-15 Toyama Chemical Co Ltd Novedosos derivado de acido antranilico o sal del mismo.
ES2714198T3 (es) 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US7930013B2 (en) 2005-06-29 2011-04-19 Compumedics Limited Sensor assembly with conductive bridge
WO2007014137A2 (en) 2005-07-21 2007-02-01 Rensselaer Polytechnic Institute 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
US8163701B2 (en) 2005-08-19 2012-04-24 Signature Therapeutics, Inc. Prodrugs of active agents
TW200801513A (en) 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
US20100130512A1 (en) 2007-05-16 2010-05-27 Rensselaer Polytechnic Institute Fused-ring heterocycle opioids
AU2008286979B2 (en) 2007-08-09 2013-03-28 Rensselaer Polytechnic Institute Quaternary opioid carboxamides
WO2010000020A1 (en) 2008-06-30 2010-01-07 Cathrx Ltd A catheter
CA2731429C (en) * 2008-07-21 2016-12-13 Mark P. Wentland Large substituent, non-phenolic amine opioids
WO2011000020A1 (en) 2009-06-12 2011-01-06 Sbc Research Pty Ltd Enhanced method of detection
AU2011232628B2 (en) 2010-03-22 2015-04-09 Rensselaer Polytechnic Institute Morphinane derivatives containing a carboxamide group as opioid receptor ligands

Similar Documents

Publication Publication Date Title
JP2013522368A5 (enExample)
JP2014505660A5 (enExample)
JP2012521428A5 (enExample)
JP2020528431A5 (enExample)
DK2582366T3 (en) A pharmaceutical combination for the treatment of pain.
JP2007530694A5 (enExample)
JP2010077141A5 (enExample)
JP2014532730A5 (ja) オピオイド受容体の調節物質およびそれを含む薬学的組成物
JP2012521429A5 (enExample)
RU2015131006A (ru) ЗАМЕЩЕННОЕ ПРОИЗВОДНОЕ СПИРОПИРИДО[1,2-a]ПИРАЗИНА И ЕГО ПРИМЕНЕНИЕ В МЕДИЦИНЕ В КАЧЕСТВЕ ИНГИБИТОРА ИНТЕГРАЗЫ ВИРУСА ИММУНОДЕФИЦИТА ЧЕЛОВЕКА (ВИЧ)
JP2012525393A5 (enExample)
JP2011509309A5 (enExample)
EP2548568A3 (en) Melanocortin receptor ligands
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
JP2014505017A5 (enExample)
RU2010126056A (ru) Органические соединения
JP2010523476A5 (enExample)
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
RU2019141734A (ru) Терапевтические соединения и композиции и способы их применения
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
AU2009220931B2 (en) N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
JP2015502371A5 (enExample)
EA022994B1 (ru) Способ подавления толерантности к опиоидному анальгетику
JP2007510741A5 (enExample)
JP2019529460A5 (enExample)